{
    "SPADE_UN_11973": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11973",
            "Peptide Name": "FK13-a7 (Derived from FK13)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "WKRWVRRWKRWLR",
            "Sequence Length": 13,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.28161291] Gram-positive bacteria :Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);Gram-negative bacteria :Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",
            "Hemolytic Activity": "[Ref.28161291] HC50=138.0 μM against human red blood cells",
            "Cytotoxicity": "[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a7 is 100.2%, 112.8%, 97.0%, 95.1%, 83.4% and 83.8% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.The cell viablity of human keratinocyte HaCaT induced by FK1",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C97H146N34O14",
            "Mass": 2012.42,
            "PI": 12.0,
            "Net Charge": 7,
            "Hydrophobicity": -1.99,
            "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria",
            "Literature": [
                {
                    "Title": "LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.",
                    "Pubmed ID": "28161291",
                    "Reference": "Biochim Biophys Acta Biomembr. 2017 May;1859(5)722-733. doi 10.1016/j.bbamem.2017.01.037.",
                    "Author": "Rajasekaran G, Kim EY, Shin SY",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28161291"
                },
                {
                    "Title": "LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity",
                    "Pubmed ID": "",
                    "Author": "Rajasekaran G, Kim EY, Shin SY"
                }
            ],
            "Frequent Amino Acids": "RWK",
            "Absent Amino Acids": "ACDEFGHIMNOPQSTUY",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 6,
            "Polar Residues": 8,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_12601",
                    "Similarity": 1.0,
                    "Sequence": "RWKR"
                },
                {
                    "SPADE_ID": "SPADE_UN_05337",
                    "Similarity": 1.0,
                    "Sequence": "VGRWKRRRW"
                },
                {
                    "SPADE_ID": "SPADE_UN_20252",
                    "Similarity": 1.0,
                    "Sequence": "RWKR"
                }
            ]
        }
    }
}